Filing metadata

Accession number
0001567619-22-007790
Form type
Form 3
Filer
4D Molecular Therapeutics, Inc.
CIK
CIK 1650648
Filed
Mar 31, 2022
Reporting period
Mar 21, 2022
Description
Initial ownership

Explore SEC Filings Hub